GUM_1: Chewing Gum on Postoperative Ileus in Children

Sponsor
University of Manitoba (Other)
Overall Status
Recruiting
CT.gov ID
NCT03666377
Collaborator
(none)
140
1
2
49
2.9

Study Details

Study Description

Brief Summary

Traditional postoperative care has been challenged recently to improve and speedup recovery (including the return of bowel function) such that patients can be discharged to home more quickly. This approach includes earlier mobilization of the patient, and introducing solid food sooner. Additionally, there is evidence in adults to suggest that "sham feeding" by chewing gum may also speed up bowel recovery so the patient may tolerate a solid diet earlier.

The aim of this study is to determine if gum chewing can enhance bowel recovery in children who undergo abdominal surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Gum chewing
N/A

Detailed Description

After intestinal surgery, many patients suffer from a "postoperative ileus" (POI). The cause is multifactorial and can be attributed to surgery itself, the lingering effect of the anesthetic, the use of narcotics and decreased mobility of the patient.

An ileus can delay the time to full diet, thus lengthening the hospital stay of the patient - sometimes up to several weeks.

There is evidence that early drinking/eating and increased mobility may accelerate the return of bowel function. "Fast-tracking" is well documented in the adult literature; protocols have been put in place to enhance GI tract recovery and thus decrease the morbidity of a prolonged hospital stay and ileus. "Fast-tracking" has been done in pediatric patients but not in a large RCT for abdominal surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study is a prospective randomized, controlled trial.This study is a prospective randomized, controlled trial.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Impact of Chewing Gum on Postoperative Ileus in Children Who Undergo Abdominal Surgery: a Prospective, Randomized, Controlled Pilot Study
Actual Study Start Date :
Dec 1, 2018
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: No gum chewing

Usual pharmacologic treatment and post-operative care (e.g. daily visits by surgical team, antibiotics where appropriate, mobilization, advancement of diet as tolerated). Analgesia and anti-emetics will be provided (both oral and intravenous) as needed.

Experimental: Gum chewing

Usual pharmacologic treatment and post-operative care (e.g. daily visits by surgical team, antibiotics where appropriate, mobilization, advancement of diet as tolerated). Analgesia and anti-emetics will be provided (both oral and intravenous) as needed. Intervention: 1 piece of sugarless gum to be chewed three times daily for 1 hour each.

Other: Gum chewing
1 piece of sugarless gum to be chewed three times daily for 1 hour each.

Outcome Measures

Primary Outcome Measures

  1. Composite outcome: first flatus, first bowel movement, first solid oral intake (any) [From time of leaving the operating room (time zero) until the time of event (first bowel movement, first flatus, first oral intake) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in hours]

    Documented by nurse, patient or caregiver

Secondary Outcome Measures

  1. Length of stay [From day of entering the operating room (time zero) until the time of event (day of discharge) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in days]

    From day admission to day of discharge

  2. Readmission [From day of discharge (time zero) until the time of event (day of readmission) or date of death of any cause, whichever comes first, assessed up to 30 days, measured in days]

    Need for readmission within 30 days of discharge

  3. Swallowing/aspiration of gum [From day of entering the operating room (time zero) until the time of event (swallowing/aspiration of gum) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/no]

    Measured as yes/no

  4. Allergic reaction/adverse reaction to gum [From day of entering the operating room (time zero) until the time of event (allergic reaction/adverse reaction to gum) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/no]

    Measured as yes/no

  5. Re-operation [From day of entering the operating room (time zero) until the time of event (Re-operation) or date of death of any cause, whichever comes first, assessed up to 30 days, measured as yes/no]

    Measured as yes/no

  6. Need for prokinetic/anti-reflux medication [From time of leaving the operating room (time zero) until the time of event (ordering of prokinetic/anti-reflux medication) or date of death of any cause, whichever comes first, assessed up to 30days, measured in hours]

    Measured as yes/no if need for additional medications to facilitate return of bowel function

  7. Narcotic use [From time of leaving the operating room (time zero) until the time of event (ordering of narcotic medication) or date of death of any cause, whichever comes first, assessed up to 30days, measured in hours]

    Quantity of narcotics consumed (mg/kg total)

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Children more than or equal to 4 years of age

  • Children who undergo abdominal surgery (both laparoscopic or open)

  • Children who have an expected postoperative length of stay more than 24 hours

Exclusion Criteria:
  • Children who are less than 4 years of age

  • Children who are unable to chew gum/swallow (e.g. intubated, decreased level of consciousness, cognitive or physical disability)

  • Children or their parents are not willing to sign consent

  • Children or their parents are unable to follow directions regarding gum chewing,

  • Children who have a GI dysmotility disorder (e.g. chronic intestinal pseudo-obstruction)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Hospital of Winnipeg/Manitoba Winnipeg Manitoba Canada R3A 1S1

Sponsors and Collaborators

  • University of Manitoba

Investigators

  • Principal Investigator: Anna Shawyer, MD, MSc, University of Manitoba

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anna Shawyer, Pediatric Surgeon, University of Manitoba
ClinicalTrials.gov Identifier:
NCT03666377
Other Study ID Numbers:
  • B2018:008
First Posted:
Sep 11, 2018
Last Update Posted:
Jan 10, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 10, 2022